Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-d-aspartate receptors

Neuroscience

Volumn 158, Issue 2, 2009, Pages 465-473

  Alen F ^a   Santos, A ^a   Moreno Sanz, G ^a   Gonzalez Cuevas G ^a   Gine E ^a   Franco Ruiz, L ^a   Navarro, M ^a   Lopez Moreno J A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

alcohol relapse; amygdala; cannabinoid; CNR1; glutamate; NR1

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; CANNABINOID; CANNABINOID RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RELAPSE; WISTAR RAT;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BENZOXAZINES; BINDING SITES; CANNABINOIDS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; MALE; MAZE LEARNING; MORPHOLINES; NAPHTHALENES; QUINOLONES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, N-METHYL-D-ASPARTATE; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 58149458647     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.10.002     Document Type: Article

References (45)

1. Alen F., Moreno-Sanz G., Isabel de Tena A., Brooks R.D., López-Jimenez A., Navarro M., and López-Moreno J.A. Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse. Eur J Neurosci 27 (2008) 3292-3298
2. Allman J.M., Hakeem A., Erwin J.M., Nimchinsky E., and Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 935 (2001) 107-117
3. Asúa T., Bilbao A., Gorriti M.A., López-Moreno J.A., Del Mar Álvarez M., Navarro M., de Fonseca F.R., Perez-Castillo A., and Santos A. Implication of the endocannabinoid system in the locomotor hyperactivity associated with congenital hypothyroidism. Endocrinology 149 (2008) 2657-2666
4. Bäckström P., and Hyytiä P. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol Clin Exp Res 28 (2004) 558-565
5. Blair H.T., Schafe G.E., Bauer E.P., Rodrigues S.M., and LeDoux J.E. Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 8 (2001) 229-242
6. Cardinal R.N., Parkinson J.A., Hall J., and Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26 (2002) 321-352
7. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29 (2006) 37-76
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
9. Danysz W., and Parsons C.G. Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50 (1998) 597-664
10. Darstein M.B., Landwehrmeyer G.B., and Feuerstein T.J. Changes in NMDA receptor subunit gene expression in the rat brain following withdrawal from forced long-term ethanol intake. Naunyn Schmiedebergs Arch Pharmacol 361 (2000) 206-213
11. De Witte P. Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict Behav 29 (2004) 1325-1339
12. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., and Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 146 (2005) 4292-4301
13. Furukawa H., Singh S.K., Mancusso R., and Gouaux E. Subunit arrangement and function in NMDA receptors. Nature 438 (2005) 185-192
14. Gerdeman G.L., Ronesi J., and Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5 (2002) 446-451
15. Gerdeman G.L., and Lovinger D.M. Emerging roles for endocannabinoids in long-term synaptic depression. Br J Pharmacol 140 (2003) 781-789
16. Gessa G.L., Serra S., Vacca G., Carai M.A., and Colombo G. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 40 (2005) 46-53
17. In: Herman H.H. (Ed). Glutamate and addiction (2002), Humana Press, Totowa, NJ
18. Hoffman P.L. NMDA receptors in alcoholism. Int Rev Neurobiol 56 (2003) 35-82
19. Hurley M.J., Mash D.C., and Jenner P. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. J Neural Transm 110 (2003) 1279-1288
20. Kotlinska J., and Liljequist S. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures. Psychopharmacology 127 (1996) 238-244
21. Langen B., and Fink H. Anxiety as a predictor of alcohol preference in rats?. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 961-968
22. López-Moreno J.A., Trigo-Díaz J.M., Rodríguez de Fonseca F., González Cuevas G., Gómez de Heras R., Crespo Galán I., and Navarro M. Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement. Neuropharmacology 47 (2004) 1036-1044
23. López-Moreno J.A., González-Cuevas G., Rodríguez-Fonseca, and Navarro M. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J Neurosci 22 (2004) 8245-8252
24. López-Moreno J.A., González-Cuevas G., Moreno-Sanz G., and Navarro M. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict Biol 13 (2008) 160-187
25. López-Moreno J.A., Scherma M., Rodríguez de Fonseca F., González-Cuevas G., Fratta W., and Navarro M. Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2. Neurosci Lett 433 (2008) 1-5
26. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168 (2005) 299-325
27. Marsicano G., and Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11 (1999) 4213-4225
28. Möller C., Wiklund L., Thorsell A., Hyytiä P., and Heilig M. Decreased measures of experimental anxiety in rats bred for high alcohol preference. Alcohol Clin Exp Res 21 (1997) 656-660
29. Nakazawa K., McHugh T.J., Wilson M.A., and Tonegawa S. NMDA receptors, place cells and hippocampal spatial memory. Nat Rev Neurosci 5 (2004) 361-372
30. Ong W.Y., and Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 92 (1999) 1177-1191
31. O'Shea M., McGregor I.S., and Mallet P.E. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol 20 (2006) 611-621
32. Preuss U.W., Koller G., Zill P., Bondy B., and Soyka M. Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur Arch Psychiatry Clin Neurosci 253 (2003) 275-280
33. Robbe D., Alonso G., Duchamp F., Bockaert J., and Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of mouse nucleus accumbens. Proc Natl Acad Sci U S A 99 (2001) 8384-8388
34. Rodd Z.A., Bell R.L., Sable H.J., Murphy J.M., and McBride W.J. Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav 79 (2004) 439-450
35. Rodd Z.A., Anstrom K.K., Knapp D.J., Racz I., Zimmer A., Serra S., Bell R.L., Woodward D.J., Breese G.R., and Colombo G. Factors mediating alcohol craving and relapse: stress, compulsivity, and genetics. Alcohol Clin Exp Res 29 (2005) 1325-1333
36. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22 (2001) 565-572
37. Schmidt W.J., and Kretschmer B.D. Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci Biobehav Rev 21 (1997) 381-392
38. Serra S., Brunetti G., Pani M., Vacca G., Carai M.A., Gessa G.L., and Colombo G. Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 443 (2002) 95-97
39. Solinas M., Yasar S., and Goldberg S.R. Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol Res 56 (2007) 393-405
40. Spanagel R. Recent animal models of alcoholism. Alcohol Res Health 24 (2000) 124-131
41. Spanagel R., and Hölter S.M. Pharmacological validation of a new animal model of alcoholism. J Neural Transm 107 (2000) 669-680
42. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., Lascorz J., Depner M., Holzberg D., Soyka M., Schreiber S., Matsuda F., Lathrop M., Schumann G., and Albrecht U. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11 (2005) 35-42
43. Subrahmanyam C.S., Cassidy B., Busch H., and Rothblum L.I. Nucleotide sequence of the region between the 18S rRNA sequence and the 28S rRNA sequence of rat ribosomal DNA. Nucleic Acids Res 10 (1982) 3667-3680
44. Vengeliene V., Siegmund S., Singer M.V., Sinclair J.D., Li T.K., and Spanagel R. A comparative study on alcohol-preferring rat lines: effects of deprivation and stress phases on voluntary alcohol intake. Alcohol Clin Exp Res 27 (2003) 1048-1054
45. Zuo L., Kranzler H.R., Luo X., Covault J., and Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 62 (2007) 616-626